Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Weiss

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Infection Control and Hospital Epidemiology|November 6, 2018
Prevalence of antibiotic-resistant organisms in Canadian Hospitals. Comparison of point-prevalence survey results from 2010, 2012, and 2016Philippe Martin, Claire Nour Abou Chakra, Victoria Williams, et al.
Biochemistry|December 30, 2015
Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular InfectivityRamalingam Venkat Kalyana Sundaram, Huiyuan Li, Lauren Bailey, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002Jeff Powis, Allison McGeer, Karen Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrheaThomas J Louie, Jennifer Peppe, C Kevin Watt, et al.
The Journal of Otolaryngology|January 7, 2003
Acute bacterial sinusitis in adults: management in the primary care settingMartin Desrosiers, Saul Frenkiel, Qutayba A Hamid, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000Andrea S Gershon, Joyce C S de Azavedo, Allison McGeer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trialsDerrick W Crook, A Sarah Walker, Yin Kean, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 27, 2007
HIV-associated lipodystrophy syndrome: A review of clinical aspectsJean-Guy Baril, Patrice Junod, Roger Leblanc, et al.
Antimicrobial Resistance and Infection Control|April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Infection Control and Hospital Epidemiology|November 6, 2018
Prevalence of antibiotic-resistant organisms in Canadian Hospitals. Comparison of point-prevalence survey results from 2010, 2012, and 2016Philippe Martin, Claire Nour Abou Chakra, Victoria Williams, et al.
Biochemistry|December 30, 2015
Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular InfectivityRamalingam Venkat Kalyana Sundaram, Huiyuan Li, Lauren Bailey, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002Jeff Powis, Allison McGeer, Karen Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrheaThomas J Louie, Jennifer Peppe, C Kevin Watt, et al.
The Journal of Otolaryngology|January 7, 2003
Acute bacterial sinusitis in adults: management in the primary care settingMartin Desrosiers, Saul Frenkiel, Qutayba A Hamid, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000Andrea S Gershon, Joyce C S de Azavedo, Allison McGeer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trialsDerrick W Crook, A Sarah Walker, Yin Kean, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 27, 2007
HIV-associated lipodystrophy syndrome: A review of clinical aspectsJean-Guy Baril, Patrice Junod, Roger Leblanc, et al.
Antimicrobial Resistance and Infection Control|April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
Pageof 7